Risk of Multiple Sclerosis Among Users of Antitumor Necrosis Factor Alpha in Four Canadian Provinces: A Population-Based Study.

Lingyi LiJ Antonio Aviña-ZubietaCharles N BernsteinGilaad G KaplanHelen TremlettHui XieJuan-Nicolás Peña-SánchezRuth Ann MarrieMahyar Etminan

Published in: Neurology (2022)

The use of anti-TNFα was associated with an increased risk of MS compared to non-users, especially among patients with RD. These findings could help clinicians and patients with RD to make more informed treatment decisions. Further studies are needed to validate these results for IBD patients.

Keyphrases

multiple sclerosis
end stage renal disease
ejection fraction
chronic kidney disease
rheumatoid arthritis
peritoneal dialysis
palliative care
white matter
combination therapy
patient reported
smoking cessation